18 results
COVID-19 Infection - Clinical Presentation and Disease Progression for Severe Cases

Via https://doi.org/10.1007/s00134-020-05967-x

#COVID19 #Hospitalization #Disease #Progression #Severe
COVID-19 Infection ... Progression for Severe ... #Progression #Severe ... #Coronavirus #Diagnosis ... #Management #Timeline
COVID-19 ARDS - Surviving Sepsis Guidelines 
Mild - Moderate - Severe

Society of Critical Care Medicine -
COVID-19 ARDS - ... Mild - Moderate - Severe ... Guidelines #ARDS #COVID19 ... #management #criticalcare
COVID-19: ICU Guidelines for the Non-Intensivist
Infection Control
Risk Factors for Severe Disease
Initial Laboratory Workup
COVID-19 Specific Medications
Respiratory
Cardiac
Hematologic
Neuro/Sedation

#COVID19 #ICU
COVID-19: ICU Guidelines ... Risk Factors for Severe ... Laboratory Workup COVID ... #ICU #criticalcare ... NonIntensivist #diagnosis #management
Running out of Analgesia and Sedation Medications due to #COVID19?  Anand Swaminathan, MD has put
Medications #management ... #covid19 #treatment ... #sarscov2 #criticalcare ... #coronavirus #medications ... sedative #analgesia #pharmacology
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
virus causing COVID ... #Coronavirus #SARS-CoV ... InfectiousDiseases #CriticalCare ... EmergencyMedicine #Pharmacology ... Virus #Antiviral #Management
Simplified Representation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Lifecycle and Potential Drug Targets

#Therapeutic
Representation of Severe ... Respiratory Syndrome Coronavirus ... Therapeutic #Targets #Pharmacology ... #SARSCOV2 #Coronavirus ... #COVID19 #JAMA
COVID-19 review…here is a list of some of the drugs that are currently being used or
COVID-19 review… ... #CoronaVirus #Treatment ... #Management #Pandemic ... Pharmacotherapy #Pharmacology ... #CriticalCare #
COVID-19 - A Seattle Intensivist's One-Page Cheat-Sheet on COVID-19 v2.7 Updated March 26 2020

(v2.7) incorporating newer
treatment section (several ... -2, 2019 Novel Coronavirus ... unilateral* • POCUS ... Cheatsheet #Diagnosis #Management ... #CriticalCare
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Siltuximab) in COVID19 ... correlate with severe ... COVID-19 Tocilizumab ... #Pharmacology # ... Management #Medications
Possible Approach to Immunosuppression in Severe COVID-19

The diagnosis and treatment of cytokine storm remains unknown and
Immunosuppression in Severe ... COVID-19 The ... #management #schema ... #criticalcare # ... algorithm #SARSCOV2 #Coronavirus